{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ANDG/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T12:16:56.222Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":5493,"canonical_name":"Andersen Group Inc.","cik":"0002065708","uei":null,"lei":null,"duns":null,"ticker":"ANDG"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":16},"count":16,"timeline":[{"ts":"2026-10-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Andersen Group Inc. — 2026-10-14","url_slug":"/sec/cik-0002065708/8-k/0002065708-26-000003","accession_number":"0002065708-26-000003","importance":35},{"ts":"2026-08-20","kind":"sec.filing","form_type":"424B4","title":"424B4 — Andersen Group Inc. — 2026-08-20","url_slug":"/sec/cik-0002065708/424b4/0001193125-26-359181","accession_number":"0001193125-26-359181","importance":55},{"ts":"2026-08-19","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Andersen Group Inc. — 2026-08-19","url_slug":"/sec/cik-0002065708/effect/9999999995-26-002713","accession_number":"9999999995-26-002713","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"S-1","title":"S-1 — Andersen Group Inc. — 2026-08-17","url_slug":"/sec/cik-0002065708/s-1/0001193125-26-354017","accession_number":"0001193125-26-354017","importance":65},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Andersen Group Inc. — 2026-08-12","url_slug":"/sec/cik-0002065708/10-q/0001193125-26-346921","accession_number":"0001193125-26-346921","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Andersen Group Inc. — 2026-08-12","url_slug":"/sec/cik-0002065708/8-k/0001193125-26-346839","accession_number":"0001193125-26-346839","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Andersen Group Inc. — 2026-08-05","url_slug":"/sec/cik-0002065708/schedule-13g/0000938206-26-000034","accession_number":"0000938206-26-000034","importance":55},{"ts":"2026-07-30","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Andersen Group Inc. — 2026-07-30","url_slug":"/sec/cik-0002065708/schedule-13g-a/0000906304-26-000145","accession_number":"0000906304-26-000145","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Andersen Group Inc. — 2026-07-28","url_slug":"/sec/cik-0002065708/schedule-13g-a/0000038777-26-000202","accession_number":"0000038777-26-000202","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"DRS","title":"DRS — Andersen Group Inc. — 2026-07-15","url_slug":"/sec/cik-0002065708/drs/0001193125-26-304950","accession_number":"0001193125-26-304950","importance":30},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Durable Capital Partners LP","title":null,"shares":336736,"price_per_share":40.01,"usd_value":13472807,"security_title":"Class A Common Stock","importance":48.47280736},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Andersen Group Inc. — 2026-06-29","url_slug":"/sec/cik-0002065708/8-k/0001193125-26-288725","accession_number":"0001193125-26-288725","importance":35},{"ts":"2026-06-23","kind":"sec.filing","form_type":"8-K","title":"8-K — Andersen Group Inc. — 2026-06-23","url_slug":"/sec/cik-0002065708/8-k/0001193125-26-278001","accession_number":"0001193125-26-278001","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Andersen Group Inc. — 2026-05-15","url_slug":"/sec/cik-0002065708/schedule-13g-a/0000938206-26-000025","accession_number":"0000938206-26-000025","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Andersen Group Inc. — 2026-05-12","url_slug":"/sec/cik-0002065708/10-q/0001193125-26-219544","accession_number":"0001193125-26-219544","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Andersen Group Inc. — 2026-05-12","url_slug":"/sec/cik-0002065708/8-k/0001193125-26-219512","accession_number":"0001193125-26-219512","importance":35}]}